Baker Bros. Advisors LP Vanda Pharmaceuticals Inc. Transaction History

Baker Bros. Advisors LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 14, 2018	SELL	$18.25 - $23.0 $5.66 Million - $7.14 Million	-310,354 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$13.95 - $19.15 $4.05 Million - $5.55 Million	-290,000 Reduced 48.3%	310,354 $5.91 Million
Q1 2018 May 15, 2018	BUY	$14.05 - $20.2 $2.48 Million - $3.56 Million	176,470 Added 41.63%	600,354 $10.1 Million
Q3 2017 Nov 14, 2017	BUY	$15.4 - $18.85 $6.53 Million - $7.99 Million	423,884	423,884 $7.59 Million

147

49.6M

49.1K

107K

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $320M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

Get notified when there are updates to the investment portfolio of Baker Bros. Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Baker Bros. Advisors LP with notifications on news.